Additionally, MDSCs support tumor progression by inducing angiogenesis, sustaining cancer stem cells (CSCs), and suppressing CD8+ T cell activation via nitric oxide synthase 2 and arginase 1 expression [134, 135]. This evidence concerns the gene CD8A and neoplasm.